Every Cure, a leading nonprofit dedicated to identifying and validating new uses for existing drugs, has officially announced an expanded collaboration with Google Cloud to advance the scope of AI-driven drug repurposing.
According to certain reports, the development in question will allow Every Cure to leverage Google Cloud’s AI tools, including Gemini 2.0 large language models, all for powering its proprietary MATRIX platform.
To understand the significance of such a development, though, we must take into account how more than 300 million people globally suffer from diseases that don’t have a dedicated treatment. Out of this humongous contingent, many also face barriers to access therapies which do exist, largely because of affordability reasons.
In response, the drug repurposing concept makes it possible to use existing therapies, which are often affordable, widely accessible generics with established safety profiles and extensive data. Bringing that into current context, through a combination of Every Cure’s mission-driven expertise and Google Cloud’s advanced AI capabilities, the partnership in question will try and transform healthcare delivery, while simultaneously enhancing patient outcomes on a worldwide scale.
Markedly enough, the whole setup is only made better by the track-record of Every Cure Leadership Team in drug repurposing. You see, the company has already advanced over a dozen repurposed treatments for diseases they weren’t initially intended for, including Castleman disease, DADA2 syndrome, POEMS syndrome, and angiosarcoma.
“We are so excited about the potential for this collaboration with Google Cloud to rapidly scale the impact that Every Cure can make on patients’ lives. We created Every Cure to treat patients with existing drugs as quickly as possible and this collaboration supercharges our ability to do this,” said David Fajgenbaum, co-founder & President of Every Cure, MD, MBA, MSc.
More on the given collaboration would reveal how it actually focuses on three key use cases. These use cases begin from scaling up the accuracy of AI-driven drug repurposing predictions. Like we briefly touched upon, Every Cure’s MATRIX platform will use Google Cloud’s AI technology, including Gemini 2.0, to analyze complex biomedical knowledge and integrate diverse data sources like omics datasets, clinical data, real-world evidence, and biomedical knowledge graphs.
Such a mechanism, on its part, will help identify overlooked therapeutic opportunities, and at the same time, accelerate hypothesis generation. Hence, with its promise to traverse unprecedented data, the partnership will enable more accurate predictions moving.
The next use case in play here relates to the validation of those predictions using accelerated preclinical testing and optimized clinical trials. Thanks to Gemini 2.0-driven trial design and predictive analytics, Every Cure can streamline in vitro and in vivo preclinical testing, alongside clinical trial workflows, to confirm efficacy and safety of repurposed drugs. Not just that, Every Cure will also use Google Cloud’s AI-powered tools to select optimal trial designs, thus orchestrating a reduced resource use and ensuring more efficient evaluation of treatments.
The third and final use case is rooted in global adoption of these validated treatments to save lives. Here, the bet will be on Good Cloud’s extensive footprint, something which Every Cure will leverage to achieve optimal presence throughout the world, particularly in underserved regions.
Among other things, we ought to mention that Every Cure and Google Cloud’s partnership will use tools like Google Kubernetes Engine (including GPUs), Ray on VertexAI, BigQuery and Cloud Storage to facilitate the secure dissemination of clinical guidelines. Beyond that, there is also a Data Studio which is to provide visual dashboards for global stakeholders.
.The collaboration under focus delivers a rather interesting follow-up to a previous link-up between Every Cure and Google Cloud, a link-up where the latter provided the neccesary support to manage comprehensive biomedical datasets and execute complex computations.
“Every Cure is doing incredible work with the power of cloud and AI technologies by repurposing medicine to save lives,” said Scott Penberthy, Senior Director of Applied AI, Office of the CTO, Google Cloud. “We’re delighted customers are tapping into the power of GPUs, TPUs, search and AI models that have been purpose built for Google systems, now available on Google Cloud. We are proud to collaborate with them on this journey.”